Zero Point Five Therapeutics
PrivateLast Round
Series C
Apr 17, 2025
Total Funding Raised
$20.2M
Company Overview
Zero Point Five Therapeutics operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series C round in April 2025.
Zero Point Five Therapeutics is a biotechnology company that develops therapeutics aimed at treating soil-transmitted helminthiasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zero Point Five Therapeutics Comparables
Compare Zero Point Five Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oxfendazole Development Group | 76% | |
| Johnson & Johnson | 72% | |
| Medicines Development for Global Health | 68% |
For institutional investors. Book with your work email.
Zero Point Five Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 17, 2025 | ||||
| Series B | Jul 19, 2023 | ||||
| Seed | Sep 2, 2022 | ||||
| Series A | Feb 5, 2021 |
For institutional investors. Book with your work email.
Zero Point Five Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Next Act Fund | Series A |
| Portfolia | Seed, Series B, Series A |
| TEDCO | Series C, Seed, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2023
$7.2M round led by Portfolia.
For institutional investors. Book with your work email.
Zero Point Five Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zero Point Five Therapeutics's valuation, stock price, and market status.
Is Zero Point Five Therapeutics a public or private company?
Zero Point Five Therapeutics is a private company.
What is the current stock price of Zero Point Five Therapeutics?
Zero Point Five Therapeutics is a private company, so its shares have no public market price. Caplight tracks Zero Point Five Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zero Point Five Therapeutics worth (valuation)?
Valuation information for Zero Point Five Therapeutics is not publicly available.
Can I buy Zero Point Five Therapeutics stock?
Zero Point Five Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zero Point Five Therapeutics's last funding round?
Zero Point Five Therapeutics's most recent funding round was Series C on April 17, 2025.
Who are the main investors in Zero Point Five Therapeutics?
Key investors in Zero Point Five Therapeutics include Portfolia.
Will Zero Point Five Therapeutics IPO soon?
No public IPO plans have been announced for Zero Point Five Therapeutics.
How can I track Zero Point Five Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Zero Point Five Therapeutics's shares on secondary markets.